Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Clinical trial NCT07201376 · RECRUITING

Trial details

NCT number: NCT07201376
Sponsor: Dartmouth-Hitchcock Medical Center
Status: RECRUITING
Study type: OBSERVATIONAL

Non-Melanoma Skin Cancer (NMSC)Benign Skin Growth

Start date: 2025-11-14
Primary completion: 2026-11-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.